Draper G J, Sanders B M, Brownbill P A, Hawkins M M
Department of Paediatrics, University of Oxford, UK.
Br J Cancer. 1992 Jul;66(1):211-9. doi: 10.1038/bjc.1992.244.
A registry including information about nearly 1,600 cases of retinoblastoma diagnosed in Britain has been created at the Childhood Cancer Research Group. Cases have been classified as 'old germ cell mutation', 'new germ cell mutation' or 'sporadic non-hereditary'. For a population-based group of 918 cases diagnosed between 1962 and 1985 we have calculated the proportions of unilateral/bilateral and hereditary/non-hereditary cases. Bilateral cases represent 40% of the total number over this period; the proportion known to be hereditary is 44%, a higher proportion than has been reported elsewhere. By following up selected groups of cases, an estimate has been made of the proportions of siblings of retinoblastoma patients and offspring of survivors from retinoblastoma who are themselves affected with the disease. Where there is no previous family history, the risk for siblings of retinoblastoma patients of developing the disease is approximately 2% if the disease in the affected child is bilateral and 1% if it is unilateral, assuming that there are no other siblings; if there are unaffected siblings the risks for subsequent children are lower. Children of patients with hereditary retinoblastoma have a one in two chance of carrying the germ cell mutation and for those who are carriers the probability of developing retinoblastoma is very close to the accepted figure of 90% if the parents have bilateral retinoblastoma but probably less if they have the unilateral form. For children of patients not known to be carriers, the probability of developing retinoblastoma is estimated to be about 1%, considerably lower than the previously accepted figure of about 5%. Retinoblastoma kindreds consist mainly of bilateral cases but there is evidence that some kindreds have a high proportion of unilateral cases. The ways in which these findings may be used in conjunction with modern techniques of molecular biology for prenatal and postnatal genetic counselling are discussed.
儿童癌症研究小组创建了一个登记处,其中包含英国近1600例视网膜母细胞瘤诊断病例的信息。病例被分类为“旧的生殖细胞突变”、“新的生殖细胞突变”或“散发性非遗传性”。对于1962年至1985年间确诊的918例基于人群的病例组,我们计算了单侧/双侧病例以及遗传性/非遗传性病例的比例。在此期间,双侧病例占总数的40%;已知为遗传性的比例为44%,高于其他地方报道的比例。通过对选定病例组的随访,对视网膜母细胞瘤患者的兄弟姐妹以及视网膜母细胞瘤幸存者的后代中受该疾病影响的比例进行了估计。如果没有家族病史,假设没有其他兄弟姐妹,视网膜母细胞瘤患者的兄弟姐妹患该疾病的风险在患病儿童为双侧时约为2%,单侧时为1%;如果有未患病的兄弟姐妹,后续孩子的风险较低。遗传性视网膜母细胞瘤患者的孩子有二分之一的机会携带生殖细胞突变,对于那些携带者,如果父母患有双侧视网膜母细胞瘤,患视网膜母细胞瘤的概率非常接近公认的90%,但如果父母患有单侧形式,可能会更低。对于未知为携带者的患者的孩子,患视网膜母细胞瘤的概率估计约为1%,远低于之前公认的约5%。视网膜母细胞瘤家族主要由双侧病例组成,但有证据表明,一些家族中单侧病例的比例很高。讨论了如何将这些发现与现代分子生物学技术结合用于产前和产后遗传咨询。